CPB vs SGMT · P/E 12, rev $10.25B vs $403.2M cap
Campbell’s Co (CPB) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
SGMT does not have a complete income-statement cache yet.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the CPB and SGMT stock pages for the full models.
Not investment advice.